4
Changes in Ownership
Perspective Therapeutics, Inc. Filed Acc 0001437749-24-002837
Director bought 127,206 shares at an average $0.71 ($90,710)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Williamson Robert F III Director | 2024-01-30 | Purchase | +18,579 | $0.71 | $13,191 | 230,134 | D: show line 1 in the form |
| Williamson Robert F III Director | 2024-01-30 | Purchase | +5,127 | $0.71 | $3,640 | 235,261 | D: show line 2 in the form |
| Williamson Robert F III Director | 2024-01-30 | Purchase | +57,121 | $0.71 | $40,556 | 292,382 | D: show line 3 in the form |
| Williamson Robert F III Director | 2024-01-30 | Purchase | +42,879 | $0.72 | $30,873 | 335,261 | D: show line 4 in the form |
| Williamson Robert F III Director | 2024-01-30 | Purchase | +3,500 | $0.70 | $2,450 | 338,761 | D: show line 5 in the form |
| Open-market purchases · 127,206 sh · avg $0.71 · $90,710 | |||||||
Loading xslF345X05/rdgdoc.xml…